Rs 172.95 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Tazloc Trio 40mg Tablet is a comprehensive antihypertensive medication designed to tackle high blood pressure through a triple-action approach. It combines Telmisartan, an angiotensin II receptor blocker that relaxes blood vessels; Amlodipine, a calcium channel blocker that improves blood flow by dilating arteries; and Hydrochlorothiazide, a diuretic that helps the body eliminate excess fluid, thereby reducing blood pressure. This combination not only effectively controls blood pressure but also significantly lowers the risk of cardiovascular events like heart attacks and strokes. Taken once daily, Tazloc Trio 40mg ensures 24-hour blood pressure regulation. It is recommended to use this medication under the guidance of a healthcare professional, especially for those with pre-existing conditions such as kidney or liver disease. Regular monitoring is essential to achieve the best outcomes and to adjust the treatment as needed for optimal cardiovascular protection.
Triple-Action Hypertension Management: Tazloc Trio 40mg Tablet combines Telmisartan (40mg), Amlodipine, and Hydrochlorothiazide, offering a comprehensive approach to managing high blood pressure (hypertension). Enhanced Cardiovascular Protection: Provides significant protection against heart attacks, strokes, and other cardiovascular events by effectively controlling blood pressure and heart rate. Diuretic for Fluid Reduction: Hydrochlorothiazide acts as a diuretic, helping reduce fluid retention, which further aids in lowering blood pressure. Kidney and Heart Health: Offers additional protection for kidney function and heart health, particularly beneficial for patients with diabetes or chronic kidney disease. Once-Daily Dosing: Convenient once-daily tablet ensures consistent blood pressure control, improving patient adherence to the treatment regimen.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s